Skip to main content
News

NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH

By April 5, 2012No Comments
NCATS

NCATS

Over the past decade, collaborative research efforts to support the discovery and development of medicines has increased dramatically. Last month, the National Institutes of Health and Eli Lilly and Company announced a new collaboration: they will generate a publicly available resource to profile the effects of thousands of approved and investigational medicines in a variety of advanced disease-relevant testing systems [1]. In-depth knowledge of the biological profiles of these medicines may enable researchers to better predict treatment outcomes, improve drug development, and lead to more specific and effective approaches.

To read the full, original article click on this link: NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH

{iframe}http://www.highlighthealth.com/health-news/nih-and-lilly-collaborate-aim-to-make-drug-development-pipelines-more-productive/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.